| Year |
Citation |
Score |
| 2007 |
Lefebvre JC, Durant J, Koechlin A, Rahelinirina V, March D, Lesimple J, Thyss S, Dellamonica P, Cottalorda J. HIV-1 and persistent clinical latency, TAR element analysis and improved method for in vitro viral reactivation Journal of Clinical Virology. 38: 348-352. PMID 17339129 DOI: 10.1016/J.Jcv.2007.01.009 |
0.35 |
|
| 2007 |
Albrecht V, Chevallier A, Bongain A, Lefebvre JC, Giordanengo V. Immunohistochemical and molecular study of severe cervical dysplasia associated with HPV-83. Gynecologic Oncology. 105: 252-5. PMID 17239429 DOI: 10.1016/J.Ygyno.2006.12.013 |
0.614 |
|
| 2006 |
Albrecht V, Chevallier A, Magnone V, Barbry P, Vandenbos F, Bongain A, Lefebvre JC, Giordanengo V. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays. Journal of Virological Methods. 137: 236-44. PMID 16879879 DOI: 10.1016/J.Jviromet.2006.06.023 |
0.622 |
|
| 2005 |
Lanteri M, Ollier L, Giordanengo V, Lefebvre JC. Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing. Breast Cancer Research : Bcr. 7: R487-94. PMID 15987454 DOI: 10.1186/Bcr1034 |
0.696 |
|
| 2004 |
Ollier L, Caramella A, Giordanengo V, Lefebvre JC. High permissivity of human HepG2 hepatoma cells for influenza viruses. Journal of Clinical Microbiology. 42: 5861-5. PMID 15583326 DOI: 10.1128/Jcm.42.12.5861-5865.2004 |
0.628 |
|
| 2004 |
Giordanengo V, Ollier L, Lanteri M, Lesimple J, March D, Thyss S, Lefebvre JC. Epigenetic reprogramming of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) in HIV-1-infected CEM T cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1961-3. PMID 15469965 DOI: 10.1096/Fj.04-2467Fje |
0.731 |
|
| 2003 |
Lantéri M, Giordanengo V, Hiraoka N, Fuzibet JG, Auberger P, Fukuda M, Baum LG, Lefebvre JC. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology. 13: 909-18. PMID 12925577 DOI: 10.1093/Glycob/Cwg110 |
0.742 |
|
| 2002 |
Lantéri M, Giordanengo V, Vidal F, Gaudray P, Lefebvre JC. A complete alpha1,3-galactosyltransferase gene is present in the human genome and partially transcribed. Glycobiology. 12: 785-92. PMID 12499400 DOI: 10.1093/Glycob/Cwf087 |
0.699 |
|
| 2002 |
Perrin C, Bayle J, Bannwarth S, Michiels JF, Heudier P, Lefebvre JC, Giordanengo V. Expression of LSLCL, a new C-type lectin, is closely restricted, in bone marrow, to immature neutrophils. Comptes Rendus De L'Academie Des Sciences. Serie Iii, Sciences De La Vie. 324: 1125-32. PMID 11803813 DOI: 10.1016/S0764-4469(01)01392-0 |
0.68 |
|
| 2001 |
Fenard D, Lambeau G, Maurin T, Lefebvre J, Doglio A. A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor. Molecular Pharmacology. 60: 341-347. PMID 11455021 DOI: 10.1124/Mol.60.2.341 |
0.392 |
|
| 1999 |
Fenard D, Lambeau G, Valentin E, Lefebvre JC, Lazdunski M, Doglio A. Secreted phospholipases A(2), a new class of HIV inhibitors that block virus entry into host cells. The Journal of Clinical Investigation. 104: 611-8. PMID 10487775 DOI: 10.1172/Jci6915 |
0.393 |
|
| 1999 |
Bannwarth S, Giordanengo V, Grosgeorge J, Turc-Carel C, Lefebvre JC. Cloning, mapping, and genomic organization of the LSLCL gene, encoding a new lymphocytic secreted mucin-like protein with a C-type lectin domain: A new model of exon shuffling. Genomics. 57: 316-7. PMID 10198175 DOI: 10.1006/Geno.1999.5762 |
0.622 |
|
| 1998 |
Cucchiarini M, Barcellini-Couget S, Lefebvre J, Doglio A. T cells chronically infected with HIV do not contain sufficient nef to promote CD4 downmodulation in the absence of envelope-mediated effects Journal of Acquired Immune Deficiency Syndromes. 17: 112-119. PMID 9473011 DOI: 10.1097/00042560-199802010-00003 |
0.446 |
|
| 1998 |
Bannwarth S, Giordanengo V, Lesimple J, Lefebvre JC. Molecular cloning of a new secreted sulfated mucin-like protein with a C-type lectin domain that is expressed in lymphoblastic cells. The Journal of Biological Chemistry. 273: 1911-6. PMID 9442024 DOI: 10.1074/Jbc.273.4.1911 |
0.672 |
|
| 1997 |
Giordanengo V, Bannwarth S, Laffont C, Van Miegem V, Harduin-Lepers A, Delannoy P, Lefebvre JC. Cloning and expression of cDNA for a human Gal(β1-3)GalNAc α2,3-sialyltransferase from the CEM T-cell line European Journal of Biochemistry. 247: 558-566. PMID 9266697 DOI: 10.1111/J.1432-1033.1997.00558.X |
0.697 |
|
| 1997 |
Giordanengo V, Limouse M, Doglio A, Lesimple J, Lefebvre JC. Alteration of CD44 expression in HIV type 1-infected T cell lines. Aids Research and Human Retroviruses. 12: 1615-22. PMID 8947296 DOI: 10.1089/Aid.1996.12.1615 |
0.703 |
|
| 1995 |
Giordanengo V, Limouse M, Peyron JF, Lefebvre JC. Lymphocytic CD43 and CD45 bear sulfate residues potentially implicated in cell to cell interactions. European Journal of Immunology. 25: 274-8. PMID 7843243 DOI: 10.1002/Eji.1830250145 |
0.662 |
|
| 1995 |
Cagnon L, Cucchiarini M, Lefebvre J, Doglio A. Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule Journal of Acquired Immune Deficiency Syndromes. 9: 349-358. DOI: 10.1097/00042560-199508000-00004 |
0.364 |
|
| 1994 |
Lefebvre JC, Giordanengo V, Doglio A, Cagnon L, Breittmayer JP, Peyron JF, Lesimple J. Altered sialylation of CD45 in HIV-1-infected T lymphocytes. Virology. 199: 265-74. PMID 8122360 DOI: 10.1006/Viro.1994.1124 |
0.709 |
|
| Show low-probability matches. |